IBMDx study

Gene: FANCM

Amber List (moderate evidence)

FANCM (Fanconi anemia complementation group M)
EnsemblGeneIds (GRCh38): ENSG00000187790
EnsemblGeneIds (GRCh37): ENSG00000187790
OMIM: 609644, Gene2Phenotype
FANCM is in 14 panels

2 reviews

vahid pazhakh (Peter MacCallum Cancer Centre)

I don't know

Various studies [PMID: 28837162, 28837157, 34793962, 31942822] have demonstrated that biallelic FANCM mutations should be considered within the spectrum of FA-like syndromes, mainly characterized by increased risk for breast and other types of cancer, and chemotherapy toxicity without preceding overt marrow failure or congenital abnormalities. In vitro cellular studies and FANCM deficient mice models [PMID: 19423727, 19561169, 25010009] support the hypersensitivity to chemotherapy agents and cancer predisposition being associated with FANCM mutations.
Created: 9 Feb 2022, 11:43 p.m. | Last Modified: 9 Feb 2022, 11:43 p.m.
Panel Version: 0.2

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
FA-like syndromes, mainly characterized by increased risk for breast and other types of cancer, and chemotherapy toxicity

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Red List (low evidence)

The association between FANCM and FA is considered REFUTED.
Created: 23 Jul 2020, 11:45 p.m. | Last Modified: 23 Jul 2020, 11:45 p.m.
Panel Version: 0.67

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Fanconi anaemia

Publications

History Filter Activity

10 Feb 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: fancm has been classified as Amber List (Moderate Evidence).

10 Feb 2022, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: FANCM were changed from Fanconi anaemia to FA-like syndromes, chemotherapy toxicity

10 Feb 2022, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: FANCM were set to

10 Feb 2022, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: FANCM was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

10 Feb 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: fancm has been classified as Amber List (Moderate Evidence).

10 Dec 2021, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: FANCM was added gene: FANCM was added to IBMDx study. Sources: IBMDx Study,Expert Review Green Mode of inheritance for gene: FANCM was set to Unknown Phenotypes for gene: FANCM were set to Fanconi anaemia